0001690279-21-000003.txt : 20210330 0001690279-21-000003.hdr.sgml : 20210330 20210330133303 ACCESSION NUMBER: 0001690279-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210330 DATE AS OF CHANGE: 20210330 EFFECTIVENESS DATE: 20210330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nacuity Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001690279 IRS NUMBER: 813011847 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-394011 FILM NUMBER: 21785423 BUSINESS ADDRESS: STREET 1: FORT WORTH CLUB BLDG. STREET 2: 306 W. 7TH STREET, SUITE 310 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817-336-3000 MAIL ADDRESS: STREET 1: FORT WORTH CLUB BLDG. STREET 2: 306 W. 7TH STREET, SUITE 310 CITY: FORT WORTH STATE: TX ZIP: 76102 D 1 primary_doc.xml X0708 D LIVE 0001690279 Nacuity Pharmaceuticals, Inc. FORT WORTH CLUB BLDG. 306 W. 7TH STREET, SUITE 310 FORT WORTH TX TEXAS 76102 817-336-3000 DELAWARE None None Corporation true 2016 Halden Conner 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Director President and Chief Executive Officer David Wohlberg 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Director Secretary Gerald Cagle 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Director Robin Steel 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Director Benjamin Yerxa 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Director Charles Lieser 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Executive Officer Chief Financial Officer Robert Ruffolo 306 West 7th Street Suite 310 Fort Worth TX TEXAS 76102 Director Biotechnology Decline to Disclose 06b false 2021-03-16 false true true true true Units comprised of Convertible Preferred Shares plus Common Stock Purchase Warrants; Common Stock issued for Warrant conversion; Convertible Preferred Shares issued for exchange of Common Stock false 10000 Maxim Group LLC 120708 Clifford Adam Teller 4631188 405 Lexington Avenue New York NY NEW YORK 10174 All States false 11000000 3171000 7829000 false 71 265600 0 Commissions include warrants to purchase 132,800 shares of Common Stock at an exercise price of $0.01 per share. 0 false Nacuity Pharmaceuticals, Inc. /s/ Halden Conner Halden Conner President and Chief Executive Officer 2021-03-30